Skip to main content

Table 3 Inference of biological classification by structural effect of mutational landscape

From: DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes

  

Structural landscape

 

Missense

Clustered

No

Clustered

Any

 

Truncating

No

Diffuse

Diffuse

Clustered

Biological classification

Oncogene

Typical (gain-of-function) for example, KRAS

None found

None found

Atypical (gain of function through loss of inhibition) for example, NPM1

Tumor suppressor

Atypical (dominant negative, gain-of-function)

Typical (loss-of-function)

Atypical (possible dominant negative, gain-of-function*)

None found

for example, SMARCA4 in lymphoma

for example, RB1

for example, TP53 in UCEC or DNMT3A in AML

  1. Inferring the biological role of OGs and TSGs in cancer via the mutational landscape can lead to borderline results in the classification. While for the majority of known cancer genes there is a clear correspondence between the mutational landscape and the biological classification, other genes require a careful evaluation to assess their functional characteristics (Figure 4).
  2. *A mixed mutational landscape with diffuse truncating and clustered missense in the same tumor type must be carefully analyzed. We should understand whether truncating and missense mutations are mutually exclusive and what is the allelic status (heterozygosity or homozygosity) of the two different patterns.